Last updated: August 18, 2026

Examiner: CHESTNUT, BARRY A

Tech Center 1600 • Art Units: 1637 1648 1671 1672

This examiner grants 73% of resolved cases

Performance Statistics

73.4%

Allow Rate

+13.4% vs TC avg

756

Total Applications

+6.3%

Interview Lift

990

Avg Prosecution Days

Based on 743 resolved cases, 2023–2026

4.6%

§101 Eligibility

20.4%

§102 Novelty

43.1%

§103 Obviousness

22.4%

§112 Clarity

App #	Title	Status	Assignee
18363050	GLYCAN MODIFIED NUCLEIC ACIDS, METHODS OF PREPARATION, AND THERAPEUTIC USES	Non-Final OA	The Board of Trustees of the Leland Stanford Junior University
18701156	MRNA VACCINE DESIGN VIA THE ALTERATION OF CODON USAGE	Non-Final OA	The Cleveland Clinic Foundation
18699032	INFLUENZA VACCINES	Non-Final OA	Cambridge Enterprise Limited
18480009	USE AND DETECTION METHOD OF FLAVIVIRUS PROTEIN MICROARRAY	Non-Final OA	NATIONAL CHENG KUNG UNIVERSITY

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.